The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows.

The YouGov poll, released Friday, shows that at least 80 percent of respondents have heard at least "a little bit" about semaglutide, a medication used to treat Type 2 diabetes that also helps a user to shed weight.

In March 2023, only 60 percent of Americans were aware of the drug. A year later, in March 2024, that number had jumped to 70 percent, the pollster noted. The latest survey also shows that the share of those who have heard "a lot" about the medication has nearly doubled since 2023, increasing to 41 percent from 23 percent.

Just 36 percent of respondents say they know someone who has taken semaglutide. Ar

See Full Page